Production (Stage)
Surgery Partners, Inc.
SGRY
$22.80
$0.200.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.17% | 17.54% | 14.29% | 14.16% | 7.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.17% | 17.54% | 14.29% | 14.16% | 7.69% |
| Cost of Revenue | 9.25% | 16.43% | 16.64% | 13.52% | 5.62% |
| Gross Profit | 4.25% | 20.66% | 7.06% | 16.29% | 15.90% |
| SG&A Expenses | 8.43% | 72.25% | -20.65% | 29.17% | 3.75% |
| Depreciation & Amortization | 7.72% | 9.00% | 73.70% | 42.62% | 0.00% |
| Other Operating Expenses | -- | -116.28% | -83.33% | -441.67% | -150.00% |
| Total Operating Expenses | 9.47% | 17.29% | 16.99% | 14.72% | 5.01% |
| Operating Income | -0.88% | 18.57% | -0.99% | 10.93% | 30.82% |
| Income Before Tax | -101.05% | 40.80% | -66.77% | -33.27% | 7,275.00% |
| Income Tax Expenses | -- | 1,913.33% | 45.16% | 162.82% | 375.00% |
| Earnings from Continuing Operations | -101.23% | -199.79% | -78.45% | -50.78% | 1,925.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.91% | -29.77% | -10.12% | -13.14% | -40.61% |
| Net Income | -204.03% | -10,750.00% | -546.94% | -182.01% | 50.20% |
| EBIT | -0.88% | 18.57% | -0.99% | 10.93% | 30.82% |
| EBITDA | 1.45% | 16.89% | 15.59% | 17.16% | 20.72% |
| EPS Basic | -202.64% | -10,646.25% | -544.10% | -181.77% | 50.53% |
| Normalized Basic EPS | -106.71% | 9.64% | -1,400.00% | 10.22% | 20.57% |
| EPS Diluted | -200.00% | -10,646.25% | -528.00% | -181.93% | 50.00% |
| Normalized Diluted EPS | -106.71% | 9.64% | -1,400.00% | 8.99% | 20.57% |
| Average Basic Shares Outstanding | 0.50% | 0.35% | 0.34% | 0.33% | 0.61% |
| Average Diluted Shares Outstanding | 0.50% | 0.35% | 0.34% | -0.97% | 0.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |